Delivery Order SPE2DB20D1004-SPE2DB25FNJFR
Award Date 7/9/25
Potential Completion Date 7/10/25
Potential Value $1.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injectors in 0.5 mL quantities, with a contract ceiling value of $32,050.85. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through competitive procurement. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and...
- The Defense Logistics Agency awarded a $40,182 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 21, 2026, for the supply of Zepbound 7.5 mg/0.5 ml pen injections. This competitively awarded, non-set-aside contract with an ultimate completion date of January 22, 2026, represents a task order under AmerisourceBergen's parent company Cencora Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 through December 31, 2031. The...
- The Defense Logistics Agency awarded a $7,428.28 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injections. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 11, 2025, and performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zepbound is a branded semaglutide injection used in diabetes and weight management treatment, consistent...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections with a ceiling value of $8,805.91. This is a firm fixed-price delivery order with an ultimate completion date of June 3, 2025, and represents a non-competitive set-aside award. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's headquarters location. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $14,239.24 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pen injectors on September 15, 2025, with completion targeted for September 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Zepbound is a semaglutide injection used for weight management and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections, with a contract ceiling value of $5,144.31. This is a firm fixed-price delivery order with an ultimate completion date of August 28, 2025, and represents a non-set-aside, competitively awarded procurement. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $7,206.82 to AmerisourceBergen Drug Corp for the supply of Zepbound 15 mg/0.5 mL pen injections on October 27, 2025. This firm fixed-price delivery order, which is part of a larger indefinite delivery contract, represents a competitive award with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 28, 2025....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections, with a ceiling value of $1,525.20. This firm fixed-price delivery order is scheduled for completion by August 1, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a non-set-aside competitive procurement under the company's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $2,675.64 to AmerisourceBergen Drug Corp for Zepbound 15 mg/0.5 mL pen injectors on November 6, 2025, with completion scheduled for November 7, 2025. This non-compete, firm fixed-price delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a $13,289.04 delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections on December 17, 2025, with an ultimate completion date of December 18, 2025. This delivery order represents a firm fixed price, competitively awarded contract with no set-aside designation, issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...